LAVAL, Quebec, Sept. 16, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, reports on its Rights Offering announced on June 17, 2011, which ended on September 14, 2011 at 4PM eastern time.
